Tuesday 16 Apr 2024
By
main news image

SINGAPORE (Nov 13): DBS is initiating its “Buy” call on Singapore Medical Group (SMG) with a target price of 75 Singaporean cents, on the back of continued robust growth post a successful turnaround.

In a Monday report, analyst Andy Sim projects the group’s core earnings growth of 292%/32% in FY17F/18F, on the back of further scaling up of its diagnostics business; recent acquisitions; and margin expansion from larger scale of operations.

SMG’s diagnostics business has continued to reap rewards post its successful turnaround, and has a new expanded 5,500-sqft facility in Novena. Its overseas ventures in...(click on link for full story on theedgesingapore.com)
 

      Print
      Text Size
      Share